Bactolife empowers worldwide health through a fortified gut microbiome
Bactolife has raised €65M across 3 funding rounds from 5 investors, most recently a Series B round in Jan 2026. Based in Copenhagen, Denmark; active in Healthtech. Data as of 7 Aug 2026.
Timing: too soon vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2026-01-08 | Series B | €30M | Athos Capital,Cross Border Impact Ventures,EIFO,Novo Holdings | View deal → |
| 2023-08-09 | Series A | €30M | The Bill & Melinda Gates Foundation,Athos Capital,Novo Holdings | View deal → |
| 2022-08-30 | Other | €5.0M | The Bill & Melinda Gates Foundation | View deal → |
